StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Rating) in a research note issued to investors on Monday morning. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Trading Down 0.5 % Brooklyn ImmunoTherapeutics stock opened at $1.99 on Monday. The company has a market capitalization of $117.06 million, a […]